Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing.
Li JR, Arsang-Jang S, Cheng Y, Sun F, D'Souza A, Dhakal B, Hari P, Huang Q, Auer P, Li Y, Urrutia R, Zhan F, Shaughnessy JD Jr, Janz S, Dong J, Cheng C.
Li JR, et al. Among authors: cheng y, cheng c.
Blood Cancer J. 2024 Mar 6;14(1):38. doi: 10.1038/s41408-024-01024-8.
Blood Cancer J. 2024.
PMID: 38443358
Free PMC article.